Peptic Ulcer

Vonoprazan was noninferior to high-dose IV proton pump inhibitor therapy in preventing 30-day rebleeding among patients with high-risk peptic ulcer bleeding who had achieved endoscopic hemostasis, according to data.

CHARLOTTE, N.C. — Endoscopic therapy yielded lower rates of rebleeding, mortality and surgery compared with conservative therapy in patients with bleeding peptic ulcer diseases, according to a presenter at ACG Annual Scientific Meeting.

In this podcast episode, we interview Barry Marshall, AC, FRACP, FRS, FAA, the legendary Nobel Laureate who discovered that peptic ulcer disease was caused by the bacteria Helicobacter pylori, not excess acid.

Treatment to eradicate Helicobacter pylori infection decreased the risk for gastric cancer among first-degree relatives of individuals with the malignancy, according to results of a randomized study published in The New England Journal of Medicine.

SAN ANTONIO — Patients with upper gastrointestinal bleeding treated with large, over-the-scope hemoclips experienced lower rates of rebleeding and severe complications, according to data presented at the American College of Gastroenterology Annual Meeting.